Menopause symptom study pulled before enrolling a single patient
NCT ID NCT07038070
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if adding a hyaluronic acid-based vaginal moisturizer to standard vaginal estrogen therapy provides extra relief for menopause-related vaginal symptoms. It planned to enroll postmenopausal women aged 45 and older who had not used these treatments recently. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENITOURINARY SYNDROME OF MENOPAUSE (GSM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gel ease menopause symptoms that disrupt daily life?
- Blue light could soothe vaginal disorders without hormones
- Breast cancer survivors face hidden menopause burden
- Laser therapy offers hope for cancer survivors with menopause symptoms
- Could radio waves ease menopause symptoms? new trial investigates
- New cream aims to boost laser therapy results for vaginal atrophy